Yeomans Consulting Group Inc. Invests $434,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Yeomans Consulting Group Inc. purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 730 shares of the biotechnology company’s stock, valued at approximately $434,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Groupama Asset Managment purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA bought a new stake in Axon Enterprise during the third quarter valued at about $120,553,000. International Assets Investment Management LLC purchased a new position in Axon Enterprise in the third quarter valued at about $871,860,000. Westfield Capital Management Co. LP raised its holdings in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in shares of Axon Enterprise by 328.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after buying an additional 111,405 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 over the last 90 days. 6.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of analyst reports. JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Axon Enterprise Stock Performance

AXON opened at $613.38 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67. The firm has a 50 day moving average of $617.43 and a two-hundred day moving average of $467.42. The firm has a market capitalization of $46.77 billion, a PE ratio of 158.50, a P/E/G ratio of 6.09 and a beta of 1.04.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.